Increased Expressions of ICAM-2 and ICAM-3 in Pterygium

References

• Liu L, Wu J, Geng J, Yuan Z, Huang D. Geographical prevalence and risk factors for pterygium: a systematic review and meta-analysis. BMJ Open. 2013;3(11):e003787. doi:10.1136/bmjopen-2013-003787.
   PubMed Web of Science ®Google Scholar
• Liu T, Liu Y, Xie L, He X, Bai J. Progress in the pathogenesis of pterygium. Curr Eye Res. 2013;38(12):1191–97. doi:10.3109/02713683.2013.823212.
   PubMed Web of Science ®Google Scholar
• Han SB, Jeon HS, Kim M, Lee SJ, Yang HK, Hwang JM, Kim KG, Hyon JY, Wee WR. Quantification of astigmatism induced by pterygium using automated image analysis. Cornea. 2016;35(3):370–76. doi:10.1097/ICO.0000000000000728.
   PubMed Web of Science ®Google Scholar
• Cárdenas-Cantú E, Zavala J, Valenzuela J, Valdez-García JE. Molecular basis of pterygium development. Semin Ophthalmol. 2016;31(6):567–83. doi:10.3109/08820538.2014.971822.
   PubMed Web of Science ®Google Scholar
• Lyck R, Enzmann G. The physiological roles of ICAM-1 and ICAM-2 in neutrophil migration into tissues. Curr Opin Hematol. 2015;22(1):53–59. doi:10.1097/MOH.0000000000000103.
   PubMed Web of Science ®Google Scholar
• Del Pozo MA, Pulido R, Muñoz C, Alvarez V, Humbría A, Campanero MR, Sánchez-Madrid F. Regulation of ICAM-3 (CD50) membrane expression on human neutrophils through a proteolytic shedding mechanism. Eur J Immunol. 1994;24(11):2586–94. doi:10.1002/eji.1830241104.
   PubMed Web of Science ®Google Scholar
• Juan M, Mullol J, Roca-Ferrer J, Fuentes M, Pérez M, Vilardell C, Yagüe J, Picado C. Regulation of ICAM-3 and other adhesion molecule expressions on eosinophils in vitro. Effects of dexamethasone. Allergy. 1999;54:1293–98.
   PubMed Web of Science ®Google Scholar
• Hart SP, Ross JA, Ross K, Haslett C, Dransfield I. Molecular characterization of the surface of apoptotic neutrophils: implications for functional downregulation and recognition by phagocytes. Cell Death Differ. 2000;7(5):493–503. doi:10.1038/sj.cdd.4400680.
   PubMed Web of Science ®Google Scholar
• Beden U, Irkeç M, Orhan D, Orhan M. The roles of T-lymphocyte subpopulations (CD4 and CD8), intercellular adhesion molecule-1 (ICAM-1), HLA-DR receptor, and mast cells in etiopathogenesis of pterygium. Ocul Immunol Inflamm. 2003;11:115–22.
   PubMed Web of Science ®Google Scholar
• Tekelioglu Y, Turk A, Avunduk AM, Yulug E. Flow cytometrical analysis of adhesion molecules, T-lymphocyte subpopulations and inflammatory markers in pterygium. Ophthalmologica. 2006;220(6):372–78. doi:10.1159/000095863.
   PubMed Web of Science ®Google Scholar
• Tan DT, Chee SP, Dear KB, Lim AS. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol. 1997;115:1235–40.
   PubMed Web of Science ®Google Scholar
• Tabur S, Oztuzcu S, Oguz E, Demiryürek S, Dagli H, Alasehirli B, Ozkaya M, Demiryürek AT. Evidence for elevated (LIMK2 and CFL1) and suppressed (ICAM1, EZR, MAP2K2, and NOS3) gene expressions in metabolic syndrome. Endocrine. 2016;53(2):465–70. doi:10.1007/s12020-016-0910-0.
   PubMed Web of Science ®Google Scholar
• Di Girolamo N, McCluskey P, Lloyd A, Coroneo MT, Wakefield D. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:671–79.
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Tamura M, Takeda K, Ogi K, Nakagaki T, Koyama R, Idogawa M, Hiratsuka H, Tokino T. Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target. Oncotarget. 2016;7(38):61426–37. doi:10.18632/oncotarget.11366.
   PubMedGoogle Scholar
• Ljubojević V, Gajanin R, Amidzić L, Vujković Z. The expression and significance of p53 protein and Ki-67 protein in pterygium. Vojnosanit Pregl. 2016;73:16–20.
   PubMed Web of Science ®Google Scholar
• de Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med. 1991;174:253–67.
   PubMed Web of Science ®Google Scholar
• Finsterbusch M, Voisin MB, Beyrau M, Williams TJ, Nourshargh S. Neutrophils recruited by chemoattractants in vivo induce microvascular plasma protein leakage through secretion of TNF. J Exp Med. 2014;211(7):1307–14. doi:10.1084/jem.20132413.
   PubMed Web of Science ®Google Scholar
• Szekanecz Z, Haines GK, Lin TR, Harlow LA, Goerdt S, Rayan G, Koch AE. Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis. Arthritis Rheum. 1994;37:221–31.
   PubMed Web of Science ®Google Scholar
• López-Briones S, Portales-Pérez DP, Baranda L, de la Fuente H, Rosenstein Y, González-Amaro R. Stimulation through CD50 preferentially induces apoptosis of TCR1+ human peripheral blood lymphocytes. Cell Adhes Commun. 1998;6:465–79.
   PubMed Web of Science ®Google Scholar
• Moffatt OD, Devitt A, Bell ED, Simmons DL, Gregory CD. Macrophage recognition of ICAM-3 on apoptotic leukocytes. J Immunol. 1999;162:6800–10.
   PubMed Web of Science ®Google Scholar
• Kessel JM, Hayflick J, Weyrich AS, Hoffman PA, Gallatin M, McIntyre TM, Prescott SM, Zimmerman GA. Coengagement of ICAM-3 and Fc receptors induces chemokine secretion and spreading by myeloid leukocytes. J Immunol. 1998;160:5579–87.
   PubMed Web of Science ®Google Scholar
• Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol. 1998;236:702–08.
   PubMed Web of Science ®Google Scholar
• Marcovich AL, Morad Y, Sandbank J, Huszar M, Rosner M, Pollack A, Herbert M, Bar-Dayan Y. Angiogenesis in pterygium: morphometric and immunohistochemical study. Curr Eye Res. 2002;25:17–22.
   PubMed Web of Science ®Google Scholar
• Fukuhara J, Kase S, Ohashi T, Ando R, Dong Z, Noda K, Ohguchi T, Kanda A, Ishida S. Expression of vascular endothelial growth factor C in human pterygium. Histochem Cell Biol. 2013;139(2):381–89. doi:10.1007/s00418-012-1019-z.
   PubMed Web of Science ®Google Scholar
• Mak RK, Chan TC, Marcet MM, Choy BN, Shum JW, Shih KC, Wong IY, Ng AL. Use of anti-vascular endothelial growth factor in the management of pterygium. Acta Ophthalmol. 2017;95(1):20–27. doi:10.1111/aos.13178.
   PubMed Web of Science ®Google Scholar
• Liu J, Xu JH, Xu W, Liang GL, Lou JX, Wang Y, Wen JQ, Cao YB. Bevacizumab as adjuvant therapy in the management of pterygium: a systematic review and Meta-analysis. Int J Ophthalmol. 2017;10(7):1126–33. doi:10.18240/ijo.2017.07.17.
   PubMed Web of Science ®Google Scholar
• Huang MT, Mason JC, Birdsey GM, Amsellem V, Gerwin N, Haskard DO, Ridley AJ, Randi AM. Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis. Blood. 2005;106(5):1636–43. doi:10.1182/blood-2004-12-4716.
   PubMed Web of Science ®Google Scholar
• Amsellem V, Dryden NH, Martinelli R, Gavins F, Almagro LO, Birdsey GM, Haskard DO, Mason JC, Turowski P, Randi AM. ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling. Cell Commun Signal. 2014;12:12. doi:10.1186/1478-811X-12-2.
   PubMed Web of Science ®Google Scholar
• Appleby SL, Cockshell MP, Pippal JB, Thompson EJ, Barrett JM, Tooley K, Sen S, Sun WY, Grose R, Nicholson I, et al. Characterization of a distinct population of circulating human non-adherent endothelial forming cells and their recruitment via intercellular adhesion molecule-3. PLoS One. 2012;7(11):e46996. doi:10.1371/journal.pone.0046996.
   PubMed Web of Science ®Google Scholar
• McLaughlin F, Hayes BP, Horgan CM, Beesley JE, Campbell CJ, Randi AM. Tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta down-regulate intercellular adhesion molecule (ICAM)-2 expression on the endothelium. Cell Adhes Commun. 1998;6:381–400.
   PubMed Web of Science ®Google Scholar
• Perez OD, Kinoshita S, Hitoshi Y, Payan DG, Kitamura T, Nolan GP, Lorens JB. Activation of the PKB/AKT pathway by ICAM-2. Immunity. 2002;16:51–65.
   PubMed Web of Science ®Google Scholar